Global Antidiabetic SGLT-2 Inhibitor Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Antidiabetic SGLT-2 Inhibitor Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Antidiabetic SGLT-2 Inhibitor by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Antidiabetic SGLT-2 Inhibitor by Country/Region, 2017, 2022 & 2028

2.2 Antidiabetic SGLT-2 Inhibitor Segment by Type

2.2.1 Canagliflozin

2.2.2 Empagliflozin

2.2.3 Dapagliflozin

2.2.4 Other

2.3 Antidiabetic SGLT-2 Inhibitor Sales by Type

2.3.1 Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Type (2017-2022)

2.3.2 Global Antidiabetic SGLT-2 Inhibitor Revenue and Market Share by Type (2017-2022)

2.3.3 Global Antidiabetic SGLT-2 Inhibitor Sale Price by Type (2017-2022)

2.4 Antidiabetic SGLT-2 Inhibitor Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Other

2.5 Antidiabetic SGLT-2 Inhibitor Sales by Application

2.5.1 Global Antidiabetic SGLT-2 Inhibitor Sale Market Share by Application (2017-2022)

2.5.2 Global Antidiabetic SGLT-2 Inhibitor Revenue and Market Share by Application (2017-2022)

2.5.3 Global Antidiabetic SGLT-2 Inhibitor Sale Price by Application (2017-2022)

3 Global Antidiabetic SGLT-2 Inhibitor by Company

3.1 Global Antidiabetic SGLT-2 Inhibitor Breakdown Data by Company

3.1.1 Global Antidiabetic SGLT-2 Inhibitor Annual Sales by Company (2020-2022)

3.1.2 Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Company (2020-2022)

3.2 Global Antidiabetic SGLT-2 Inhibitor Annual Revenue by Company (2020-2022)

3.2.1 Global Antidiabetic SGLT-2 Inhibitor Revenue by Company (2020-2022)

3.2.2 Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Company (2020-2022)

3.3 Global Antidiabetic SGLT-2 Inhibitor Sale Price by Company

3.4 Key Manufacturers Antidiabetic SGLT-2 Inhibitor Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Antidiabetic SGLT-2 Inhibitor Product Location Distribution

3.4.2 Players Antidiabetic SGLT-2 Inhibitor Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Antidiabetic SGLT-2 Inhibitor by Geographic Region

4.1 World Historic Antidiabetic SGLT-2 Inhibitor Market Size by Geographic Region (2017-2022)

4.1.1 Global Antidiabetic SGLT-2 Inhibitor Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Antidiabetic SGLT-2 Inhibitor Annual Revenue by Geographic Region

4.2 World Historic Antidiabetic SGLT-2 Inhibitor Market Size by Country/Region (2017-2022)

4.2.1 Global Antidiabetic SGLT-2 Inhibitor Annual Sales by Country/Region (2017-2022)

4.2.2 Global Antidiabetic SGLT-2 Inhibitor Annual Revenue by Country/Region

4.3 Americas Antidiabetic SGLT-2 Inhibitor Sales Growth

4.4 APAC Antidiabetic SGLT-2 Inhibitor Sales Growth

4.5 Europe Antidiabetic SGLT-2 Inhibitor Sales Growth

4.6 Middle East & Africa Antidiabetic SGLT-2 Inhibitor Sales Growth

5 Americas

5.1 Americas Antidiabetic SGLT-2 Inhibitor Sales by Country

5.1.1 Americas Antidiabetic SGLT-2 Inhibitor Sales by Country (2017-2022)

5.1.2 Americas Antidiabetic SGLT-2 Inhibitor Revenue by Country (2017-2022)

5.2 Americas Antidiabetic SGLT-2 Inhibitor Sales by Type

5.3 Americas Antidiabetic SGLT-2 Inhibitor Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Antidiabetic SGLT-2 Inhibitor Sales by Region

6.1.1 APAC Antidiabetic SGLT-2 Inhibitor Sales by Region (2017-2022)

6.1.2 APAC Antidiabetic SGLT-2 Inhibitor Revenue by Region (2017-2022)

6.2 APAC Antidiabetic SGLT-2 Inhibitor Sales by Type

6.3 APAC Antidiabetic SGLT-2 Inhibitor Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Antidiabetic SGLT-2 Inhibitor by Country

7.1.1 Europe Antidiabetic SGLT-2 Inhibitor Sales by Country (2017-2022)

7.1.2 Europe Antidiabetic SGLT-2 Inhibitor Revenue by Country (2017-2022)

7.2 Europe Antidiabetic SGLT-2 Inhibitor Sales by Type

7.3 Europe Antidiabetic SGLT-2 Inhibitor Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Antidiabetic SGLT-2 Inhibitor by Country

8.1.1 Middle East & Africa Antidiabetic SGLT-2 Inhibitor Sales by Country (2017-2022)

8.1.2 Middle East & Africa Antidiabetic SGLT-2 Inhibitor Revenue by Country (2017-2022)

8.2 Middle East & Africa Antidiabetic SGLT-2 Inhibitor Sales by Type

8.3 Middle East & Africa Antidiabetic SGLT-2 Inhibitor Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Antidiabetic SGLT-2 Inhibitor

10.3 Manufacturing Process Analysis of Antidiabetic SGLT-2 Inhibitor

10.4 Industry Chain Structure of Antidiabetic SGLT-2 Inhibitor

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Antidiabetic SGLT-2 Inhibitor Distributors

11.3 Antidiabetic SGLT-2 Inhibitor Customer

12 World Forecast Review for Antidiabetic SGLT-2 Inhibitor by Geographic Region

12.1 Global Antidiabetic SGLT-2 Inhibitor Market Size Forecast by Region

12.1.1 Global Antidiabetic SGLT-2 Inhibitor Forecast by Region (2023-2028)

12.1.2 Global Antidiabetic SGLT-2 Inhibitor Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Antidiabetic SGLT-2 Inhibitor Forecast by Type

12.7 Global Antidiabetic SGLT-2 Inhibitor Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Antidiabetic SGLT-2 Inhibitor Product Offered

13.1.3 Pfizer Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 AstraZeneca

13.2.1 AstraZeneca Company Information

13.2.2 AstraZeneca Antidiabetic SGLT-2 Inhibitor Product Offered

13.2.3 AstraZeneca Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AstraZeneca Main Business Overview

13.2.5 AstraZeneca Latest Developments

13.3 Johnson & Johnson

13.3.1 Johnson & Johnson Company Information

13.3.2 Johnson & Johnson Antidiabetic SGLT-2 Inhibitor Product Offered

13.3.3 Johnson & Johnson Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Johnson & Johnson Main Business Overview

13.3.5 Johnson & Johnson Latest Developments

13.4 GlaxoSmithKline

13.4.1 GlaxoSmithKline Company Information

13.4.2 GlaxoSmithKline Antidiabetic SGLT-2 Inhibitor Product Offered

13.4.3 GlaxoSmithKline Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 GlaxoSmithKline Main Business Overview

13.4.5 GlaxoSmithKline Latest Developments

13.5 Merck & Co

13.5.1 Merck & Co Company Information

13.5.2 Merck & Co Antidiabetic SGLT-2 Inhibitor Product Offered

13.5.3 Merck & Co Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Merck & Co Main Business Overview

13.5.5 Merck & Co Latest Developments

13.6 Eli Lilly

13.6.1 Eli Lilly Company Information

13.6.2 Eli Lilly Antidiabetic SGLT-2 Inhibitor Product Offered

13.6.3 Eli Lilly Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Eli Lilly Main Business Overview

13.6.5 Eli Lilly Latest Developments

13.7 Sanofi

13.7.1 Sanofi Company Information

13.7.2 Sanofi Antidiabetic SGLT-2 Inhibitor Product Offered

13.7.3 Sanofi Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Sanofi Main Business Overview

13.7.5 Sanofi Latest Developments

13.8 Takeda Pharmaceuticals

13.8.1 Takeda Pharmaceuticals Company Information

13.8.2 Takeda Pharmaceuticals Antidiabetic SGLT-2 Inhibitor Product Offered

13.8.3 Takeda Pharmaceuticals Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Takeda Pharmaceuticals Main Business Overview

13.8.5 Takeda Pharmaceuticals Latest Developments

13.9 Novo Nordisk

13.9.1 Novo Nordisk Company Information

13.9.2 Novo Nordisk Antidiabetic SGLT-2 Inhibitor Product Offered

13.9.3 Novo Nordisk Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Novo Nordisk Main Business Overview

13.9.5 Novo Nordisk Latest Developments

13.10 Servier Laboratories

13.10.1 Servier Laboratories Company Information

13.10.2 Servier Laboratories Antidiabetic SGLT-2 Inhibitor Product Offered

13.10.3 Servier Laboratories Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Servier Laboratories Main Business Overview

13.10.5 Servier Laboratories Latest Developments

13.11 Boehringer Ingelheim

13.11.1 Boehringer Ingelheim Company Information

13.11.2 Boehringer Ingelheim Antidiabetic SGLT-2 Inhibitor Product Offered

13.11.3 Boehringer Ingelheim Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Boehringer Ingelheim Main Business Overview

13.11.5 Boehringer Ingelheim Latest Developments

13.12 Bristol-Myers Squibb

13.12.1 Bristol-Myers Squibb Company Information

13.12.2 Bristol-Myers Squibb Antidiabetic SGLT-2 Inhibitor Product Offered

13.12.3 Bristol-Myers Squibb Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Bristol-Myers Squibb Main Business Overview

13.12.5 Bristol-Myers Squibb Latest Developments

14 Research Findings and Conclusion

Table 1. Antidiabetic SGLT-2 Inhibitor Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Antidiabetic SGLT-2 Inhibitor Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Canagliflozin

Table 4. Major Players of Empagliflozin

Table 5. Major Players of Dapagliflozin

Table 6. Major Players of Other

Table 7. Global Antidiabetic SGLT-2 Inhibitor Sales by Type (2017-2022) & (K Pcs)

Table 8. Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Type (2017-2022)

Table 9. Global Antidiabetic SGLT-2 Inhibitor Revenue by Type (2017-2022) & ($ million)

Table 10. Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Type (2017-2022)

Table 11. Global Antidiabetic SGLT-2 Inhibitor Sale Price by Type (2017-2022) & (USD/Pcs)

Table 12. Global Antidiabetic SGLT-2 Inhibitor Sales by Application (2017-2022) & (K Pcs)

Table 13. Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Application (2017-2022)

Table 14. Global Antidiabetic SGLT-2 Inhibitor Revenue by Application (2017-2022)

Table 15. Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Application (2017-2022)

Table 16. Global Antidiabetic SGLT-2 Inhibitor Sale Price by Application (2017-2022) & (USD/Pcs)

Table 17. Global Antidiabetic SGLT-2 Inhibitor Sales by Company (2020-2022) & (K Pcs)

Table 18. Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Company (2020-2022)

Table 19. Global Antidiabetic SGLT-2 Inhibitor Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Company (2020-2022)

Table 21. Global Antidiabetic SGLT-2 Inhibitor Sale Price by Company (2020-2022) & (USD/Pcs)

Table 22. Key Manufacturers Antidiabetic SGLT-2 Inhibitor Producing Area Distribution and Sales Area

Table 23. Players Antidiabetic SGLT-2 Inhibitor Products Offered

Table 24. Antidiabetic SGLT-2 Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Antidiabetic SGLT-2 Inhibitor Sales by Geographic Region (2017-2022) & (K Pcs)

Table 28. Global Antidiabetic SGLT-2 Inhibitor Sales Market Share Geographic Region (2017-2022)

Table 29. Global Antidiabetic SGLT-2 Inhibitor Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Antidiabetic SGLT-2 Inhibitor Sales by Country/Region (2017-2022) & (K Pcs)

Table 32. Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Country/Region (2017-2022)

Table 33. Global Antidiabetic SGLT-2 Inhibitor Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Antidiabetic SGLT-2 Inhibitor Sales by Country (2017-2022) & (K Pcs)

Table 36. Americas Antidiabetic SGLT-2 Inhibitor Sales Market Share by Country (2017-2022)

Table 37. Americas Antidiabetic SGLT-2 Inhibitor Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Country (2017-2022)

Table 39. Americas Antidiabetic SGLT-2 Inhibitor Sales by Type (2017-2022) & (K Pcs)

Table 40. Americas Antidiabetic SGLT-2 Inhibitor Sales Market Share by Type (2017-2022)

Table 41. Americas Antidiabetic SGLT-2 Inhibitor Sales by Application (2017-2022) & (K Pcs)

Table 42. Americas Antidiabetic SGLT-2 Inhibitor Sales Market Share by Application (2017-2022)

Table 43. APAC Antidiabetic SGLT-2 Inhibitor Sales by Region (2017-2022) & (K Pcs)

Table 44. APAC Antidiabetic SGLT-2 Inhibitor Sales Market Share by Region (2017-2022)

Table 45. APAC Antidiabetic SGLT-2 Inhibitor Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Region (2017-2022)

Table 47. APAC Antidiabetic SGLT-2 Inhibitor Sales by Type (2017-2022) & (K Pcs)

Table 48. APAC Antidiabetic SGLT-2 Inhibitor Sales Market Share by Type (2017-2022)

Table 49. APAC Antidiabetic SGLT-2 Inhibitor Sales by Application (2017-2022) & (K Pcs)

Table 50. APAC Antidiabetic SGLT-2 Inhibitor Sales Market Share by Application (2017-2022)

Table 51. Europe Antidiabetic SGLT-2 Inhibitor Sales by Country (2017-2022) & (K Pcs)

Table 52. Europe Antidiabetic SGLT-2 Inhibitor Sales Market Share by Country (2017-2022)

Table 53. Europe Antidiabetic SGLT-2 Inhibitor Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Country (2017-2022)

Table 55. Europe Antidiabetic SGLT-2 Inhibitor Sales by Type (2017-2022) & (K Pcs)

Table 56. Europe Antidiabetic SGLT-2 Inhibitor Sales Market Share by Type (2017-2022)

Table 57. Europe Antidiabetic SGLT-2 Inhibitor Sales by Application (2017-2022) & (K Pcs)

Table 58. Europe Antidiabetic SGLT-2 Inhibitor Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Antidiabetic SGLT-2 Inhibitor Sales by Country (2017-2022) & (K Pcs)

Table 60. Middle East & Africa Antidiabetic SGLT-2 Inhibitor Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Antidiabetic SGLT-2 Inhibitor Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Antidiabetic SGLT-2 Inhibitor Sales by Type (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Antidiabetic SGLT-2 Inhibitor Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Antidiabetic SGLT-2 Inhibitor Sales by Application (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Antidiabetic SGLT-2 Inhibitor Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Antidiabetic SGLT-2 Inhibitor

Table 68. Key Market Challenges & Risks of Antidiabetic SGLT-2 Inhibitor

Table 69. Key Industry Trends of Antidiabetic SGLT-2 Inhibitor

Table 70. Antidiabetic SGLT-2 Inhibitor Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Antidiabetic SGLT-2 Inhibitor Distributors List

Table 73. Antidiabetic SGLT-2 Inhibitor Customer List

Table 74. Global Antidiabetic SGLT-2 Inhibitor Sales Forecast by Region (2023-2028) & (K Pcs)

Table 75. Global Antidiabetic SGLT-2 Inhibitor Sales Market Forecast by Region

Table 76. Global Antidiabetic SGLT-2 Inhibitor Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Antidiabetic SGLT-2 Inhibitor Sales Forecast by Country (2023-2028) & (K Pcs)

Table 79. Americas Antidiabetic SGLT-2 Inhibitor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Antidiabetic SGLT-2 Inhibitor Sales Forecast by Region (2023-2028) & (K Pcs)

Table 81. APAC Antidiabetic SGLT-2 Inhibitor Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Antidiabetic SGLT-2 Inhibitor Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Europe Antidiabetic SGLT-2 Inhibitor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Antidiabetic SGLT-2 Inhibitor Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Middle East & Africa Antidiabetic SGLT-2 Inhibitor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Antidiabetic SGLT-2 Inhibitor Sales Forecast by Type (2023-2028) & (K Pcs)

Table 87. Global Antidiabetic SGLT-2 Inhibitor Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Antidiabetic SGLT-2 Inhibitor Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Antidiabetic SGLT-2 Inhibitor Sales Forecast by Application (2023-2028) & (K Pcs)

Table 91. Global Antidiabetic SGLT-2 Inhibitor Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Antidiabetic SGLT-2 Inhibitor Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share Forecast by Application (2023-2028)

Table 94. Pfizer Basic Information, Antidiabetic SGLT-2 Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 95. Pfizer Antidiabetic SGLT-2 Inhibitor Product Offered

Table 96. Pfizer Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 97. Pfizer Main Business

Table 98. Pfizer Latest Developments

Table 99. AstraZeneca Basic Information, Antidiabetic SGLT-2 Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 100. AstraZeneca Antidiabetic SGLT-2 Inhibitor Product Offered

Table 101. AstraZeneca Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 102. AstraZeneca Main Business

Table 103. AstraZeneca Latest Developments

Table 104. Johnson & Johnson Basic Information, Antidiabetic SGLT-2 Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 105. Johnson & Johnson Antidiabetic SGLT-2 Inhibitor Product Offered

Table 106. Johnson & Johnson Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 107. Johnson & Johnson Main Business

Table 108. Johnson & Johnson Latest Developments

Table 109. GlaxoSmithKline Basic Information, Antidiabetic SGLT-2 Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 110. GlaxoSmithKline Antidiabetic SGLT-2 Inhibitor Product Offered

Table 111. GlaxoSmithKline Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 112. GlaxoSmithKline Main Business

Table 113. GlaxoSmithKline Latest Developments

Table 114. Merck & Co Basic Information, Antidiabetic SGLT-2 Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 115. Merck & Co Antidiabetic SGLT-2 Inhibitor Product Offered

Table 116. Merck & Co Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 117. Merck & Co Main Business

Table 118. Merck & Co Latest Developments

Table 119. Eli Lilly Basic Information, Antidiabetic SGLT-2 Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 120. Eli Lilly Antidiabetic SGLT-2 Inhibitor Product Offered

Table 121. Eli Lilly Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 122. Eli Lilly Main Business

Table 123. Eli Lilly Latest Developments

Table 124. Sanofi Basic Information, Antidiabetic SGLT-2 Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 125. Sanofi Antidiabetic SGLT-2 Inhibitor Product Offered

Table 126. Sanofi Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 127. Sanofi Main Business

Table 128. Sanofi Latest Developments

Table 129. Takeda Pharmaceuticals Basic Information, Antidiabetic SGLT-2 Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 130. Takeda Pharmaceuticals Antidiabetic SGLT-2 Inhibitor Product Offered

Table 131. Takeda Pharmaceuticals Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 132. Takeda Pharmaceuticals Main Business

Table 133. Takeda Pharmaceuticals Latest Developments

Table 134. Novo Nordisk Basic Information, Antidiabetic SGLT-2 Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 135. Novo Nordisk Antidiabetic SGLT-2 Inhibitor Product Offered

Table 136. Novo Nordisk Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 137. Novo Nordisk Main Business

Table 138. Novo Nordisk Latest Developments

Table 139. Servier Laboratories Basic Information, Antidiabetic SGLT-2 Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 140. Servier Laboratories Antidiabetic SGLT-2 Inhibitor Product Offered

Table 141. Servier Laboratories Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 142. Servier Laboratories Main Business

Table 143. Servier Laboratories Latest Developments

Table 144. Boehringer Ingelheim Basic Information, Antidiabetic SGLT-2 Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 145. Boehringer Ingelheim Antidiabetic SGLT-2 Inhibitor Product Offered

Table 146. Boehringer Ingelheim Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 147. Boehringer Ingelheim Main Business

Table 148. Boehringer Ingelheim Latest Developments

Table 149. Bristol-Myers Squibb Basic Information, Antidiabetic SGLT-2 Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 150. Bristol-Myers Squibb Antidiabetic SGLT-2 Inhibitor Product Offered

Table 151. Bristol-Myers Squibb Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 152. Bristol-Myers Squibb Main Business

Table 153. Bristol-Myers Squibb Latest Developments

List of Figures

Figure 1. Picture of Antidiabetic SGLT-2 Inhibitor

Figure 2. Antidiabetic SGLT-2 Inhibitor Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Antidiabetic SGLT-2 Inhibitor Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Antidiabetic SGLT-2 Inhibitor Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Antidiabetic SGLT-2 Inhibitor Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Canagliflozin

Figure 10. Product Picture of Empagliflozin

Figure 11. Product Picture of Dapagliflozin

Figure 12. Product Picture of Other

Figure 13. Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Type in 2021

Figure 14. Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Type (2017-2022)

Figure 15. Antidiabetic SGLT-2 Inhibitor Consumed in Hospitals

Figure 16. Global Antidiabetic SGLT-2 Inhibitor Market: Hospitals (2017-2022) & (K Pcs)

Figure 17. Antidiabetic SGLT-2 Inhibitor Consumed in Clinics

Figure 18. Global Antidiabetic SGLT-2 Inhibitor Market: Clinics (2017-2022) & (K Pcs)

Figure 19. Antidiabetic SGLT-2 Inhibitor Consumed in Other

Figure 20. Global Antidiabetic SGLT-2 Inhibitor Market: Other (2017-2022) & (K Pcs)

Figure 21. Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Application (2017-2022)

Figure 22. Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Application in 2021

Figure 23. Antidiabetic SGLT-2 Inhibitor Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Company in 2021

Figure 25. Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Geographic Region in 2021

Figure 27. Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Region (2017-2022)

Figure 28. Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Country/Region in 2021

Figure 29. Americas Antidiabetic SGLT-2 Inhibitor Sales 2017-2022 (K Pcs)

Figure 30. Americas Antidiabetic SGLT-2 Inhibitor Revenue 2017-2022 ($ Millions)

Figure 31. APAC Antidiabetic SGLT-2 Inhibitor Sales 2017-2022 (K Pcs)

Figure 32. APAC Antidiabetic SGLT-2 Inhibitor Revenue 2017-2022 ($ Millions)

Figure 33. Europe Antidiabetic SGLT-2 Inhibitor Sales 2017-2022 (K Pcs)

Figure 34. Europe Antidiabetic SGLT-2 Inhibitor Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Antidiabetic SGLT-2 Inhibitor Sales 2017-2022 (K Pcs)

Figure 36. Middle East & Africa Antidiabetic SGLT-2 Inhibitor Revenue 2017-2022 ($ Millions)

Figure 37. Americas Antidiabetic SGLT-2 Inhibitor Sales Market Share by Country in 2021

Figure 38. Americas Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Country in 2021

Figure 39. United States Antidiabetic SGLT-2 Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Antidiabetic SGLT-2 Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Antidiabetic SGLT-2 Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Antidiabetic SGLT-2 Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Antidiabetic SGLT-2 Inhibitor Sales Market Share by Region in 2021

Figure 44. APAC Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Regions in 2021

Figure 45. China Antidiabetic SGLT-2 Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Antidiabetic SGLT-2 Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Antidiabetic SGLT-2 Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Antidiabetic SGLT-2 Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Antidiabetic SGLT-2 Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Antidiabetic SGLT-2 Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Antidiabetic SGLT-2 Inhibitor Sales Market Share by Country in 2021

Figure 52. Europe Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Country in 2021

Figure 53. Germany Antidiabetic SGLT-2 Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Antidiabetic SGLT-2 Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Antidiabetic SGLT-2 Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Antidiabetic SGLT-2 Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Antidiabetic SGLT-2 Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Antidiabetic SGLT-2 Inhibitor Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Country in 2021

Figure 60. Egypt Antidiabetic SGLT-2 Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Antidiabetic SGLT-2 Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Antidiabetic SGLT-2 Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Antidiabetic SGLT-2 Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Antidiabetic SGLT-2 Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Antidiabetic SGLT-2 Inhibitor in 2021

Figure 66. Manufacturing Process Analysis of Antidiabetic SGLT-2 Inhibitor

Figure 67. Industry Chain Structure of Antidiabetic SGLT-2 Inhibitor

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles